Lumendi news

The latest news about Lumendi

Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)

Lumendi Platforms to be Discussed in Investor’s Webcast 31 March 2021 with Panel of Clinical Experts New EZ Glide, activated by water or saline, improves endoscopic performance of the DiLumen… Continue reading Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)

DiLumen online

Online Support for Clinical Cases With the current restrictions travel and in-house visits are often limited or impossible. The Lumendi team will continue to support you with the use of… Continue reading DiLumen online

ASGE Webinar Online

Upcoming ASGE Webinar: Navigating the Tortuous Colon Reimbursement for Complex Endoscopic Resection January 14th at 8pm EST (7pm CST) Join ASGE staff and Dr. Othman as they cover the following:… Continue reading ASGE Webinar Online

PIONEERING ENDOSURGERY NEW MISSION STATEMENT AT LUMENDI

Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to:

expand indication areas and procedures in the upper gastrointestinal tract, which includes a recent submission to the FDA;
innovate improvements planned for the DiLumen EIP, including a proprietary lubricated inner surface of DiLumen’s sheath for better endoscope handling performance; and
commercially release the DiLumen C2 platform[1] to bring robotic-like end-effectors to endolumenal surgery in a low-cost, disposable format to provide endoscopists with unprecedented control of tissue.

LUMENDI REPORTS FIRST INCISIONLESS APPENDECTOMY USING DOUBLE-BALLOON ENDOLUMENAL INTERVENTIONAL PLATFORM

Dr. Kantsevoy states, “Endoscopic endolumenal appendectomy is less invasive than traditional surgical, laparoscopic, transvaginal or transgastric appendectomy.

Early Trial Data Show Promise in Endoscopic Procedure Time Study

A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of Lumendi’s DiLumen device over a control group.

LUMENDI OPERATIONS AND CLINICAL SUPPORT REMAIN AVAILABLE DURING OBSERVANCE OF COVID-19 PRECAUTIONS.

We have adapted our operation and clinical support models as healthcare facilities prioritize focus on patients affected by COVID-19.

LUMENDI REPORTS SUCCESSFUL ENROLLMENT CLOSURE OF ITS DILUMEN™ ENDOLUMENAL INTERVENTIONAL PLATFORM (EIP™) STUDY

The study evaluates DiLumen’s effect on endoscopic procedure time for pre-cancerous colorectal complex polypectomies.